Adial Pharmaceuticals announced on October 15, 2024, that it commends the National Institute on Alcohol Abuse and Alcoholism (NIAAA) for its newly updated definition of recovery. This updated definition emphasizes a broader, non-abstinence approach to recovery, which directly aligns with Adial’s AD04 program.
The NIAAA's new definition, outlined in its 2025 Professional Judgement Budget, supports a more flexible approach to treating alcohol use disorder. This alignment validates Adial's therapeutic strategy, which offers patients the option of reducing drinking in addition to abstinence.
This development is important for Adial as it suggests a more contemporary and patient-focused regulatory environment. Such an environment could potentially facilitate the regulatory pathway and commercial potential for AD04, which is designed to offer flexibility in treatment outcomes.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.